Publication | Open Access

Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase

BioinformaticsChronic PhaseRadiation OncologyHematological MalignancyEngineeringMedicineMixed-phenotype Acute LeukemiaHematologyCancer GenomicsNext-generation Deep SequencingMolecular DiagnosticsSystems BiologyOncologyCell BiologyTumor BiologyMyeloid Neoplasia